image
Healthcare - Biotechnology - NASDAQ - US
$ 2.47
-1.2 %
$ 6.69 M
Market Cap
-2.04
P/E
BALANCE SHEET
9.58 M ASSETS
-28.41%
725 K LIABILITIES
-65.24%
8.85 M EQUITY
-21.60%
BALANCE SHEET DECOMPOSITION
Balance Sheet Cyclerion Therapeutics, Inc.
image
Current Assets 4.22 M
Cash & Short-Term Investments 3.23 M
Receivables 556 K
Other Current Assets 437 K
Non-Current Assets 5.35 M
Long-Term Investments 5.35 M
PP&E 0
Other Non-Current Assets 0
33.75 %5.81 %4.56 %55.87 %Total Assets$9.6m
Current Liabilities 725 K
Accounts Payable 390 K
Short-Term Debt 0
Other Current Liabilities 335 K
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0
53.79 %46.21 %Total Liabilities$725.0k

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
ASSETS
Cash & Cash Equivalents 3.2 7.6 13.4 54.0 54.4 94.9 0 0
Short Term Investments 0 0 0 0 0 0 0 0
Receivables 0.6 0 96 K 100 K 0.1 1.5 0 0
Inventory 0 0 0.8 0.9 0.8 2.0 0 0
Other Current Assets 0.4 0.5 1.3 1.4 4.0 4.8 0.9 1.3
Total Current Assets 4.2 8.0 14.8 55.5 58.5 101.2 0.9 1.3
PP&E 0 0 1.2 1.5 50.3 79.8 6.5 4.1
Intangible Assets 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0
Long Term Investments 5.3 5.3 0 0 3.8 5.0 0 0
Other Long Term Assets 0 0 2.0 2.4 2.8 0.5 25 K 80 K
Other Assets 0 0 0 0 0 0 0 0
Total Assets 9.6 13.4 18.1 59.3 115.4 186.5 7.4 5.5
LIABILITIES
Accounts Payable 0.4 1.2 3.0 1.8 1.4 3.3 2.8 1.8
Short Term Debt 0 0 0 0 6.8 6.8 0 0
Other Current Liabilities 0.3 0.9 4.7 9.3 8.7 8.1 15.1 12.2
Total Current Liabilities 0.7 2.1 7.6 11.1 17.0 18.2 17.8 14.0
Long Term Debt 0 0 0 0 38.9 70.5 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0
Total Liabilities 0.7 2.1 7.6 11.1 55.9 88.7 17.8 14.0
EQUITY
Common Stock 0 0 0 0 0 0 0 0
Retained Earnings (267.5) (264.4) (259.2) (215.1) (163.4) (85.6) 0 0
Other Accumulative Comprehensive Income/Loss 0 12 K 20 K 23 K 27 K 20 K (15.5) (15.9)
Total Equity 8.8 11.3 10.5 48.2 59.5 97.7 (10.4) (8.6)
Total Liabilities and Equity 9.6 13.4 18.1 59.3 115.4 186.5 7.4 5.5
SHARES OUTSTANDING
Common Shares Outstanding 2.5 2.3 2.2 2.0 1.5 1.4 1.4 1.4 1.4